Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07145957 · ClinicalTrials.gov registry record
Does Undergoing a Prehabilitation Protocol Aimed at Optimizing Scapulothoracic Mobility and Strengthening Improve Internal Rotation After Reverse Shoulder Arthroplasty?
A clinical trial of Primary Reverse Total Shoulder Arthroplasty, sponsored by University of Florida.
- Recruiting
- Registry status
- 64
- Enrollment target
- 1
- Study location
NCT07145957 is a study of Primary Reverse Total Shoulder Arthroplasty that is actively recruiting participants, run by University of Florida. The registered enrollment target is 64 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07145957, a study of Primary Reverse Total Shoulder Arthroplasty, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
Difficulty with internal rotation (IR) after reverse shoulder arthroplasty (RSA) is common. Current rehabilitation protocols may not optimize IR. The investigator's objective is to assess the impact of prehabilitation focused on IR strengthening and mobility on RSA outcomes. The investigators will perform a prospective, randomized control trial to achieve the specific aim: assessing range of motion, strength, patient-reported outcomes, and activities of daily living requiring internal rotation between control and prehabilitation cohorts, with the prehabilitation patients receiving 6 weeks of treatment.
Conditions Studied
Interventions
- OTHER Prehabilitation
Study Locations (1)
Florida
- University of Florida Department of Orthopaedics and Rehabilitation - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2025-11-06 |
| Est. Completion | 2028-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07145957
The ClinicalTrials.gov registry entry for NCT07145957 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Primary Reverse Total Shoulder Arthroplasty appearing as the primary indexed condition, and to 1 intervention - of which Prehabilitation is the first listed.
NCT07145957 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT07145957 about?
NCT07145957 is a clinical study titled "Does Undergoing a Prehabilitation Protocol Aimed at Optimizing Scapulothoracic Mobility and Strengthening Improve Internal Rotation After Reverse Shoulder Arthroplasty?". Difficulty with internal rotation (IR) after reverse shoulder arthroplasty (RSA) is common. Current rehabilitation protocols may not optimize IR. The investigator's objective is to assess the impact of prehabilitation focused on IR strengthening and mobility on RSA outcomes. The investigators will p...
What is the current status of trial NCT07145957?
This trial is currently recruiting. The enrollment target is 64 participants. The study started on 2025-11-06. Estimated completion is 2028-09-01.
What conditions does trial NCT07145957 study?
This clinical trial studies the following conditions: Primary Reverse Total Shoulder Arthroplasty.
What interventions are being tested in trial NCT07145957?
The interventions under investigation include: Prehabilitation (OTHER).
Who is sponsoring clinical trial NCT07145957?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07145957 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.